• CDC
  • Heart Failure
  • Cardiovascular Clinical Consult
  • Adult Immunization
  • Hepatic Disease
  • Rare Disorders
  • Pediatric Immunization
  • Implementing The Topcon Ocular Telehealth Platform
  • Weight Management
  • Screening
  • Monkeypox
  • Guidelines
  • Men's Health
  • Psychiatry
  • Allergy
  • Nutrition
  • Women's Health
  • Cardiology
  • Substance Use
  • Pediatrics
  • Kidney Disease
  • Genetics
  • Complimentary & Alternative Medicine
  • Dermatology
  • Endocrinology
  • Oral Medicine
  • Otorhinolaryngologic Diseases
  • Pain
  • Gastrointestinal Disorders
  • Geriatrics
  • Infection
  • Musculoskeletal Disorders
  • Obesity
  • Rheumatology
  • Technology
  • Cancer
  • Nephrology
  • Anemia
  • Neurology
  • Pulmonology

Aspirin Reduces COVID-19 Mortality: Investigator's Insights

Video

Dr Jonathan Chow reviews study findings that patients with COVID-19 taking low-dose aspirin had reduced risk for use of ICU, mechanical ventilation, and of death.

Principal investigator Jonathan Chow, MD, assistant professor of anesthesiology at the University of Maryland School of Medicine, highlights study results and discusses possible mechanisms.

For details of Dr Chow's study, see: Low-dose Aspirin Reduces Risk of COVID-19 Mortality in Hospitalized Patients.

Recent Videos
"Vaccination is More of a Marathon than a Sprint"
Vaccines are for Kids, Booster Fatigue, and Other Obstacles to Adult Immunization
New Research Amplifies Impact of Social Determinants of Health on Cardiometabolic Measures Over Time
Related Content
Investigational Oral Muvalaplin Reduces Lp(a) by Up to 85% in High-Risk Adults: Phase 2 Data / image credit Stephen Nicholls, MBBS, PhD Monash University

Investigational Oral Agent Muvalaplin Reduces Lp(a) by Up to 85% in High-Risk Adults: Phase 2 Data

Mary Caffrey
November 19th 2024
Article

Lp(a) is a genetically-driven and independent risk factor for CVD with no approved treatments. Lilly is advancing muvalaplin and has some good competition.

Navigating Cardiovascular Complications of Obesity: Expert Insights for Primary Care

Navigating Cardiovascular Complications of Obesity: Expert Insights for Primary Care

Sydney Jennings
August 30th 2023
Podcast

Listen to our latest podcast episode for details on top CVD risk factors to screen patients with obesity for, medications to help prevent CVD, and more.

©Kurhan/AdobeStock

Aprocitentan Now Available in the US for Treatment-Resistant Hypertension

Sydney Jennings
November 15th 2024
Article

Aprocitentan is the first-and-only dual endothelin receptor antagonist approved for the treatment of systemic hypertension.

Respiratory Tripledemic 2022-23: An Expert Recap

Respiratory Tripledemic 2022-23: An Expert Recap

Sydney Jennings
April 6th 2023
Podcast

William Schaffner, MD, medical director of the NFID, provides an expert recap of the 2022-2023 respiratory virus season for primary care clinicians.

FDA Lifts Clinical Hold on Novavax’s COVID-19-Influenza Combination Vaccine / Image credit: ©Kateryna_Kon/AdobeStock

FDA Lifts Clinical Hold on Novavax’s COVID-19-Influenza Combination Vaccine

Sydney Jennings
November 12th 2024
Article

The FDA cleared Novavax to start enrolling the planned phase 3 trial after a safety concern was found to be unrelated to the combination vaccine.

November Issue of Patient Care Online Digital Edition is Now Live / Image credit: ©MJH Life Sciences

November Issue of Patient Care Online Digital Edition is Now Live

Sydney Jennings
November 11th 2024
Article

Find details on the surge in US pertussis cases, the first self-administered flu vaccine, and study findings underscoring the evolving nature of long COVID.

© 2024 MJH Life Sciences

All rights reserved.